Data model aims to predict lung cancer therapy outcomes
NCT ID NCT07388771
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a computer model can predict how well non-small cell lung cancer responds to chemotherapy and immunotherapy given before surgery. Researchers will collect data from 500 participants to build and test this prediction tool. The goal is to improve treatment decisions, but no new treatment is being tested.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOADJUVANT THERAPY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sir Run Run Shaw Hospital
RECRUITINGHangzhou, Zhejiang, 430030, China
-
Tongji hospital
RECRUITINGWuhan, Hubei, 430030, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Four-Drug combo erase Triple-Negative breast cancer before surgery?
- Can a pill keep lung cancer from returning after surgery?
- Aiming to spare lung cancer patients from chemo: a smarter Pre-Surgery plan?
- Can a Two-Target antibody shrink Hard-to-Treat cancers?
- Can extended poziotinib use keep cancer in check?
- Can zapping tumors before surgery boost lung cancer treatment?